Scotia Capital »

ImmunoGen shares owned by Scotia Capital

Quarter-by-quarter ownership of ImmunoGen shares owned by Scotia Capital from 13F filings

Historical chart of Scotia Capital investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Scotia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Scotia Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $567k 19k 29.65
2023-09-30 $238k 15k 15.87
2023-06-30 $249k 13k 18.87
2023-03-31 $62k 16k 3.84
2022-12-31 $80k 16k 4.96
2022-09-30 $77k 16k 4.75
2022-06-30 $73k 16k 4.50
2022-03-31 $77k 16k 4.76
2021-12-31 $117k 16k 7.40
2021-09-30 $123k 22k 5.67
2021-06-30 $144k 22k 6.60
2021-03-31 $177k 22k 8.11
2020-12-31 $141k 22k 6.45
2020-09-30 $73k 20k 3.60
2020-06-30 $104k 22k 4.66
2020-03-31 $59k 17k 3.40
2019-12-31 $90k 18k 5.10
2019-09-30 $40k 17k 2.41
2019-06-30 $36k 17k 2.17
2019-03-31 $45k 17k 2.72
2018-12-31 $55k 12k 4.76
2018-09-30 $103k 11k 9.48
2018-06-30 $113k 11k 10.40
2018-03-31 $114k 11k 10.49
2017-12-31 $74k 12k 6.40
2017-09-30 $91k 12k 7.66
2017-06-30 $97k 14k 7.14
2014-09-30 $200k 19k 10.56
2014-06-30 $238k 20k 11.88
2014-03-31 $293k 20k 14.95